In an investigation by Hadamitzky et al., it was observed that the acute administration of rapamycin upregulated the level of FKBP51 in the brain of mice experiencing psychiatric diseases, while repeated administration did not affect FKBP51 levels (191, 192). This evidence concerns the gene FKBP4 and psychiatric disorder.